European Committee signs off on Paxene for Kaposi's sarcoma treatment.
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D017277:Drug Approval; D005060:Europe; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D012514:Sarcoma, Kaposi / Q000188:drug therapy*
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel